|
|
|
| The Progress of Nuclear Nanomedicines |
| ZHANG Huaming;LUO Shunzhong;WEI Hongyuan |
| Institute of Nuclear Physics and Chemistry, China Academy of engineering Physics, Mian yang 621999, China |
|
|
|
|
Abstract This manuscript briefly summarized the progress in the last decade and predicted the development in the future of nano-radiopharmaceuticals. The major carrier materials for nanoparticle delivery are biomaterials such as liposomes, or biocompatible materials such as phosphates, hydroxyapatite. Currently, various radionuclides, such as 131I, 111In, 125I, 166Ho, 177Lu, 90Y, 225Ac are extensively used clinically or in research for diagnostic or therapeutic purpose. The preparation methodology of nano-radiopharmaceuticals includes post-irradiation activation, encapsulation, adsorption and etc. Many pre-clinical trials showed that nano-radiopharmaceuticals had displayed good specificity on cancer diagnosis and treatment, thus had became an important research direction in the diagnosis and treatment of cancer and personalized medical care.
|
|
|
|
|
|
| ［1］ |
Chen F, Ehlerding E B, Cai W. Theranostic nanoparticles［J］. Journal of Nuclear Medicine Official Publication Society of Nuclear Medicine, 2014, 55(12): 1 919-1922.
|
| ［2］ |
Phillips W T , Bao A, Brenner A J ,et al.Image-guided nterventional therapy for cancer with radiotherapeutic nanoparticles［J］. Advanced Drug Delivery Reviews, 2014, (12628): 21.
|
| ［3］ |
Mirza A Z, Siddiqui F A. Nanomedicine and drug delivery: a mini review［J］. International Nano Letters, 2014, 4(1): 94.
|
| ［4］ |
Marmorato P, Simonelli F, Abbas K,et al. 56Co-labelled radioactive Fe3O4 nanoparticles for in vitro uptake studies on Balb/3T3 and Caco2 cell lines［J］. J Nanopart Res , 2011,13: 6707-6716.
|
| ［5］ |
Nijsen F, Rook D, Brandt C, et al.Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study［J］. European Journal of Nuclear Medicine, 2001, 28（6）: 743-749 .
|
| ［6］ |
Ehlerding E B, Goel S, Cai W.Cancer theranostics with 64Cu/177Lu-loaded liposomes［J］. Eur J Nucl Med Mol Imaging, 2016, 43: 938-940.
|
| ［7］ |
Avcba U, Avcba N, Akaln H A, et al. Synthesis and biodistribution of novel magnetic-poly(HEMA-APH) nanopolymer radiolabeled with iodine-131 and investigation its fate in vivo for cancer therapy［J］. Journal of Nanoparticle Research, 2013, 15(10): 1-24.
|
| ［8］ |
Hara E, Makino A, Kurihara K, et al. Radionuclide therapy using nanoparticle of 131I Lactosome in combination with percutaneous ethanol injection therapy［J］. Journal of Nanoparticle Research, 2013, 15(15): 1-10.
|
| ［9］ |
芮玉奎，张艳北，桂新，等. 金属及金属氧化物纳米材料的放射性标记［J］. 同位素，2013,26（1）：8-15.Rui yukui, Zhang yanbei, Gui xin, et al. Radiolabeling of metallic and metal oxide nanomaterials［J］. Journal of Isotopes, 2013, 26（1）: 8-15(in Chinese).
|
| ［10］ |
Agata P, Edyta L, Frank B, et al. Functionalized NaA nanozeolites labeled with 224,225Ra for targeted alpha therapy［J］. Journal of Nanoparticle Research, 2013, 15(11): 2082.
|
| ［11］ |
Kurihara K, Ueda M, Hara I, et al. Inflammation-induced synergetic enhancement of nanoparticle treatments with DOXIL, and 90Y Lactosome for orthotopic mammary tumor［J］. Journal of Nanoparticle Research, 2016, 18(5): 1-11.
|
| ［12］ |
IAEA. Nuclear Technology Review 2013.［EB/OL］［2017-05-25］. http:∥www.iaea.org/OurWork/ST/NE/Pess/assets/13-25751_rep_ntr_2013_web.pdf.
|
| ［13］ |
Navya P N, Daima H K. Rational engineering of physicochemical properties of nanomaterials for biomedical applications with nanotoxicological perspectives.［J］. Nano Convergence, 2016, 3(1): 1.
|
| ［14］ |
Ritz S, Kotman N, Baier G, et al. The protein corona of nanoparticles: distinct proteins regulate the cellular uptake［J］. Biomacromolecules, 2015, 16(4): 1 311-21.
|
| ［15］ |
Durán N, Silveira C P, Durán M, et al. Silver nanoparticle protein corona and toxicity: a mini-review［J］. Journal of Nanobiotechnology, 2015, 13(1): 55.
|
| ［16］ |
Mogharabi M, Abdollahi M, Faramarzi M A. Toxicity of nanomaterials; an undermined issue［J］. Daru Journal of Pharmaceutical Sciences, 2014, 22(1): 59.
|
| ［17］ |
Gomes A, Sengupta J, Datta P, et al. Physiological interactions of nanoparticles in energy metabolism, immune function and their biosafety: a review［J］. Journal of Nanoscience & Nanotechnology, 2016, 16(1): 92.
|
| ［18］ |
Walsh A A. Chemisorption of iodine-125 to gold nanoparticles allows for real-time quantitation and potential use in nanomedicine［J］. Journal of Nanoparticle Research, 2017, 19(4): 152.
|
| ［19］ |
Cedrowska, yczko E, Piotrowska M , et al. Silver impregnated nanoparticles of titanium dioxide as carriers for 211At［J］. Radiochimica Acta, 2016, 104(4): 267-275.
|
| ［20］ |
Sunderland K S, Yang M, Mao C. Phage-enabled nanomedicine: from probes to therapeutics in precision medicine［J］. Angewandte Chemie International Edition, 2016, 56(8): 1964.
|
| ［21］ |
Hadjidemetriou M, Kostarelos K. Nanomedicine: evolution of the nanoparticle corona［J］. Nature Nanotechnology, 2017: 288-290.
|
| ［22］ |
Chen fangfang , Wang guankui , Griffin J I, et al. Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo［J］. Nature Nanotechnology, 2017, 12(4): 387.
|
| ［23］ |
Mohammadi M, Ramezani M, Abnous K, et al. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine［J］. International Journal of Pharmaceutics, 2017, 519(1-2): 287.
|
| ［24］ |
Muthu M S, Singh S. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders［J］. Nanomedicine, 2009, 4(1): 105-108.
|
|
|
|
